[Once-a-week versus once-every-three-weeks cisplatin application in combined chemoradiotherapy for locally advanced head and neck cancer?]
- PMID: 29532097
- DOI: 10.1007/s00066-018-1283-5
[Once-a-week versus once-every-three-weeks cisplatin application in combined chemoradiotherapy for locally advanced head and neck cancer?]
Comment on
-
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial.J Clin Oncol. 2018 Apr 10;36(11):1064-1072. doi: 10.1200/JCO.2017.74.9457. Epub 2017 Dec 8. J Clin Oncol. 2018. PMID: 29220295 Clinical Trial.
Similar articles
-
[Taxan induction chemotherapy and concomitant chemoradiotherapy with cisplatin in patients with locally advanced head and neck cancer--early results].Pol Merkur Lekarski. 2010 Dec;29(174):357-60. Pol Merkur Lekarski. 2010. PMID: 21298984 Polish.
-
Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial.Lancet Oncol. 2015 Feb;16(2):221-32. doi: 10.1016/S1470-2045(14)71200-8. Epub 2015 Jan 15. Lancet Oncol. 2015. PMID: 25596659 Clinical Trial.
-
The efficacy of induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil combined with cisplatin concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: a matched pair analysis.Clin Oncol (R Coll Radiol). 2013 Nov;25(11):647-53. doi: 10.1016/j.clon.2013.07.007. Epub 2013 Aug 13. Clin Oncol (R Coll Radiol). 2013. PMID: 23948462
-
Chemotherapy in locally advanced head and neck squamous cell carcinoma.Cancer Treat Rev. 2016 Mar;44:10-6. doi: 10.1016/j.ctrv.2016.01.002. Epub 2016 Jan 22. Cancer Treat Rev. 2016. PMID: 26924194 Review.
-
Definitive chemoradiotherapy for squamous head and neck cancer: cisplatin versus carboplatin? A meta-analysis.Future Oncol. 2016 Dec;12(23):2755-2764. doi: 10.2217/fon-2016-0068. Epub 2016 Aug 23. Future Oncol. 2016. PMID: 27549331 Review.
Cited by
-
Addition of chemotherapy to hyperfractionated radiotherapy in advanced head and neck cancer-a meta-analysis.Strahlenther Onkol. 2019 Dec;195(12):1041-1049. doi: 10.1007/s00066-019-01511-z. Epub 2019 Oct 4. Strahlenther Onkol. 2019. PMID: 31586229 Review. English.
-
Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway.Front Oncol. 2020 Sep 10;10:1756. doi: 10.3389/fonc.2020.01756. eCollection 2020. Front Oncol. 2020. Retraction in: Front Oncol. 2021 Jun 29;11:721658. doi: 10.3389/fonc.2021.721658. PMID: 33014864 Free PMC article. Retracted.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources